Vanguard Capital Management’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
Other funds holding ASMB
SFCM
Vanguard Capital Management's ASMB Position: Q3 2026 in Review
Vanguard Capital Management increased its Assembly Biosciences (ASMB) stake by 7.9% in Q3 2026, buying an estimated $1.26M and bringing the position to 602,932 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2575.
Vanguard Capital Management first reported a position in ASMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $15.4M in Q2 2026. 104 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.
- Vanguard Capital Management held 602,932 shares of Assembly Biosciences worth $14.2M as of Q3 2026.
- Vanguard Capital Management bought 43,990 Assembly Biosciences shares in Q3 2026, an estimated $1.26M.
- Assembly Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2575 holding.
- Vanguard Capital Management first reported a position in Assembly Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Assembly Biosciences position peaked at $15.4M in Q2 2026.
- 104 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.